Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study

References

• Aboelwafa AA, Doaa AE, Aliaa NE. (2010). Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. AAPS Pharm Sci Tech 11:1591–602
   PubMed Web of Science ®Google Scholar
• Aggarwal G, Dhawan S, Kumar SLH. (2012). Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone. Drug Dev Ind Pharm 39:39–50
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, et al. (2013). Enhanced transdermal delivery of an antihypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm 443:26–38
   PubMed Web of Science ®Google Scholar
• Alsarra IA, Bosela AA, Ahmed SM, et al. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 59:485–90
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, et al. (2011). Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–52
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, et al. (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8
   PubMed Web of Science ®Google Scholar
• Barry BW. (2001). Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–14
   PubMed Web of Science ®Google Scholar
• Chopra S, Patil GV, Motwani SK. (2007). Release modulating hydrophilic matrix systems of Losartan potassium: optimization of formulation using statistical experimental design. Eur J Pharm Biopharm 66:73–82
   PubMed Web of Science ®Google Scholar
• Coderch L, Fonollosa J, De Pera M, et al. (2000). Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption. J Control Release 68:85–95
   PubMed Web of Science ®Google Scholar
• Csoka G, Marton S, Zelko R, et al. (2007). Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm 65:233–7
   PubMed Web of Science ®Google Scholar
• Draize JH, Woodard G, Calvery HD. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–90
   Web of Science ®Google Scholar
• Dubey V, Mishra D, Jain NK. (2007). Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 67:398–405
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43–55
   PubMed Web of Science ®Google Scholar
• EL-Samaligy MS, Afifi NN, Mahmoud EA. (2006). Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308:140–8
   PubMed Web of Science ®Google Scholar
• Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–9
   PubMed Web of Science ®Google Scholar
• Gannu R, Palem CR, Yamsani SK, et al. (2010). Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box Behnken statistical design. AAPS Pharm Sci Tech 11:976–85
   PubMed Web of Science ®Google Scholar
• Hal D, Jeremiasse E, Vringer T, et al. (1996). Encapsulation of lidocaine base and hydrochloride into non-ionic surfactant vesicles (NSVs) and diffusion through human stratum comeum in vitro. Eur J Pharm Sci 4:147–57
   Web of Science ®Google Scholar
• Hao Y, Zhao L, Li N, et al. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80
   PubMed Web of Science ®Google Scholar
• Harrison JE, Groundwater PE, Brain RK, et al. (1996). Azone induced fluidity in human stratum corneum. A Fourier transform infrared spectroscopy investigation using predeuterated analogue. J Control Release 41:283–90
   Web of Science ®Google Scholar
• Imam SS, Aqil M, Akhtar M, et al. (2014). Optimization of mobile phase by 32-mixture design for validation and quantification of risperidone in bulk and pharmaceutical formulations using RP-HPLC method. Anal Methods 6:282–88
   Web of Science ®Google Scholar
• Khajeh M. (2009). Application of Box–Behnken design in the optimization of a magnetic nanoparticle procedure for zinc determination in analytical samples by inductively coupled plasma optical emission spectrometry. J Haz Mater 172:385–9
   PubMed Web of Science ®Google Scholar
• Kumar M, Misra A, Babbar AK, et al. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 358:285–91
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, et al. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Salve PR, Thomas NS, et al. (2001). Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 219:95–105
   PubMed Web of Science ®Google Scholar
• Pardakhty J, Varshosaz AR. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41
   PubMed Web of Science ®Google Scholar
• Rahman Z, Zidan AS, Khan MA. (2010). Non destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm 76:127–37
   PubMed Web of Science ®Google Scholar
• Sentjurc M, Vrhovnik K, Kristl J. (1999). Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release 59:87–97
   PubMed Web of Science ®Google Scholar
• Subczynski WK, Wisniewska A. (2000). Physical properties of lipid bilayer membranes: relevance to membrane biological functions. Acta Biochim Pol 47:613–25
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–18
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Florence AT. (1995). Non-ionic surfactant vesicles (niosomes). Physical and pharmaceutical chemistry. Adv Coll Inter Sci 58:1–55
   Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70
   Web of Science ®Google Scholar
• Varshosaz J, Pardakhty A, Baharanchi SM. (2005). Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Delivery 12:75–82
   PubMed Web of Science ®Google Scholar
• Xu L, Pan J, Chen Q, et al. (2008). In vivo evaluation of the safety of triptolide loaded hydrogel thickened microemulsion. Food Chem Toxicol 46:3792–9
   PubMed Web of Science ®Google Scholar
• Yaxin L, Xing T, Yue C, et al. (2008). In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats. Eur J Pharm Biopharm 68:422–9
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20 40 60 and 80) and a sorbitan trimester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar